Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

Clinical trial NCT07264998 · RECRUITING

Trial details

NCT number: NCT07264998
Sponsor: Hubei Cancer Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Neoplasms Hormone Receptor-Positive Breast Cancer Abemaciclib Abemaciclib-related Diarrhea Drug-induced Diarrhea Gastrointestinal Microbiome (Focus)Microbiome

Start date: 2025-12-21
Primary completion: 2026-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.